First New York Securities’s Bristol-Myers Squibb BMY Stock Holding History

First New York Securities's BMY Position: Q4 2016 in Review

First New York Securities sold out of Bristol-Myers Squibb (BMY) in Q4 2016, closing a stake of 2,000 shares — an estimated $108K sold.

First New York Securities first reported a position in BMY in Q2 2014 and held it in 4 quarters. The position peaked at $2.38M in Q2 2014. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

• First New York Securities reported no remaining Bristol-Myers Squibb position as of Q4 2016 after selling out during the quarter.
• First New York Securities sold 2,000 Bristol-Myers Squibb shares in Q4 2016, an estimated $108K.
• First New York Securities first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 4 quarters.
• First New York Securities's Bristol-Myers Squibb position peaked at $2.38M in Q2 2014.
• 1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on First New York Securities's 13F filing for Q4 2016, filed 7 Feb 2017.